The global Antidepressant Medication market growth is projected to reach US$ 15210 million in 2025 to US$ 17740 million in 2031; it is expected to grow at a CAGR of 2.6% from 2025 to 2031.

Global Antidepressant Medication Market Trends And Outlook 2025-31

The global Antidepressant Medication market size is predicted to grow from US$ 15210 million in 2025 to US$ 17740 million in 2031; it is expected to grow at a CAGR of 2.6% from 2025 to 2031. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the ?Antidepressant Medication Industry Forecast? looks at past sales and reviews total world Antidepressant Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Antidepressant Medication sales for 2025 through 2031. With Antidepressant Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antidepressant Medication industry. This Insight Report provides a comprehensive analysis of the global Antidepressant Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antidepressant Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antidepressant Medication market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antidepressant Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antidepressant Medication. This report presents a comprehensive overview, market shares, and growth opportunities of Antidepressant Medication market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Monoamine Oxidase &nbsp;&nbsp;&nbsp; Tricyclic &nbsp;&nbsp;&nbsp; New Drugs Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Institute of Medicine &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Alkermes Plc &nbsp;&nbsp;&nbsp; AbbVie Inc &nbsp;&nbsp;&nbsp; Eli Lilly And Company &nbsp;&nbsp;&nbsp; GlaxoSmithKline, Inc. &nbsp;&nbsp;&nbsp; Merck KGAA &nbsp;&nbsp;&nbsp; Pfizer Inc. &nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries Ltd. (Actavis Generics) &nbsp;&nbsp;&nbsp; Takeda Pharmaceutical Limited Company. &nbsp;&nbsp;&nbsp; AstraZeneca Key Questions Addressed in this Report What is the 10-year outlook for the global Antidepressant Medication market? What factors are driving Antidepressant Medication market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Antidepressant Medication market opportunities vary by end market size? How does Antidepressant Medication break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Antidepressant Medication Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Antidepressant Medication by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Antidepressant Medication by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Antidepressant Medication Segment by Type &nbsp;2.2.1 Monoamine Oxidase &nbsp;2.2.2 Tricyclic &nbsp;2.2.3 New Drugs &nbsp;2.3 Antidepressant Medication Sales by Type &nbsp;2.3.1 Global Antidepressant Medication Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Antidepressant Medication Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Antidepressant Medication Sale Price by Type (2020-2025) &nbsp;2.4 Antidepressant Medication Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Institute of Medicine &nbsp;2.4.3 Clinic &nbsp;2.4.4 Others &nbsp;2.5 Antidepressant Medication Sales by Application &nbsp;2.5.1 Global Antidepressant Medication Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Antidepressant Medication Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Antidepressant Medication Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Antidepressant Medication Breakdown Data by Company &nbsp;3.1.1 Global Antidepressant Medication Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Antidepressant Medication Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Antidepressant Medication Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Antidepressant Medication Revenue by Company (2020-2025) &nbsp;3.2.2 Global Antidepressant Medication Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Antidepressant Medication Sale Price by Company &nbsp;3.4 Key Manufacturers Antidepressant Medication Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Antidepressant Medication Product Location Distribution &nbsp;3.4.2 Players Antidepressant Medication Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Antidepressant Medication by Geographic Region &nbsp;4.1 World Historic Antidepressant Medication Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Antidepressant Medication Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Antidepressant Medication Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Antidepressant Medication Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Antidepressant Medication Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Antidepressant Medication Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Antidepressant Medication Sales Growth &nbsp;4.4 APAC Antidepressant Medication Sales Growth &nbsp;4.5 Europe Antidepressant Medication Sales Growth &nbsp;4.6 Middle East & Africa Antidepressant Medication Sales Growth 5 Americas &nbsp;5.1 Americas Antidepressant Medication Sales by Country &nbsp;5.1.1 Americas Antidepressant Medication Sales by Country (2020-2025) &nbsp;5.1.2 Americas Antidepressant Medication Revenue by Country (2020-2025) &nbsp;5.2 Americas Antidepressant Medication Sales by Type (2020-2025) &nbsp;5.3 Americas Antidepressant Medication Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Antidepressant Medication Sales by Region &nbsp;6.1.1 APAC Antidepressant Medication Sales by Region (2020-2025) &nbsp;6.1.2 APAC Antidepressant Medication Revenue by Region (2020-2025) &nbsp;6.2 APAC Antidepressant Medication Sales by Type (2020-2025) &nbsp;6.3 APAC Antidepressant Medication Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Antidepressant Medication by Country &nbsp;7.1.1 Europe Antidepressant Medication Sales by Country (2020-2025) &nbsp;7.1.2 Europe Antidepressant Medication Revenue by Country (2020-2025) &nbsp;7.2 Europe Antidepressant Medication Sales by Type (2020-2025) &nbsp;7.3 Europe Antidepressant Medication Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Antidepressant Medication by Country &nbsp;8.1.1 Middle East & Africa Antidepressant Medication Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Antidepressant Medication Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Antidepressant Medication Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Antidepressant Medication Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Antidepressant Medication &nbsp;10.3 Manufacturing Process Analysis of Antidepressant Medication &nbsp;10.4 Industry Chain Structure of Antidepressant Medication 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Antidepressant Medication Distributors &nbsp;11.3 Antidepressant Medication Customer 12 World Forecast Review for Antidepressant Medication by Geographic Region &nbsp;12.1 Global Antidepressant Medication Market Size Forecast by Region &nbsp;12.1.1 Global Antidepressant Medication Forecast by Region (2026-2031) &nbsp;12.1.2 Global Antidepressant Medication Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Antidepressant Medication Forecast by Type (2026-2031) &nbsp;12.7 Global Antidepressant Medication Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Alkermes Plc &nbsp;13.1.1 Alkermes Plc Company Information &nbsp;13.1.2 Alkermes Plc Antidepressant Medication Product Portfolios and Specifications &nbsp;13.1.3 Alkermes Plc Antidepressant Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Alkermes Plc Main Business Overview &nbsp;13.1.5 Alkermes Plc Latest Developments &nbsp;13.2 AbbVie Inc &nbsp;13.2.1 AbbVie Inc Company Information &nbsp;13.2.2 AbbVie Inc Antidepressant Medication Product Portfolios and Specifications &nbsp;13.2.3 AbbVie Inc Antidepressant Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 AbbVie Inc Main Business Overview &nbsp;13.2.5 AbbVie Inc Latest Developments &nbsp;13.3 Eli Lilly And Company &nbsp;13.3.1 Eli Lilly And Company Company Information &nbsp;13.3.2 Eli Lilly And Company Antidepressant Medication Product Portfolios and Specifications &nbsp;13.3.3 Eli Lilly And Company Antidepressant Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Eli Lilly And Company Main Business Overview &nbsp;13.3.5 Eli Lilly And Company Latest Developments &nbsp;13.4 GlaxoSmithKline, Inc. &nbsp;13.4.1 GlaxoSmithKline, Inc. Company Information &nbsp;13.4.2 GlaxoSmithKline, Inc. Antidepressant Medication Product Portfolios and Specifications &nbsp;13.4.3 GlaxoSmithKline, Inc. Antidepressant Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 GlaxoSmithKline, Inc. Main Business Overview &nbsp;13.4.5 GlaxoSmithKline, Inc. Latest Developments &nbsp;13.5 Merck KGAA &nbsp;13.5.1 Merck KGAA Company Information &nbsp;13.5.2 Merck KGAA Antidepressant Medication Product Portfolios and Specifications &nbsp;13.5.3 Merck KGAA Antidepressant Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Merck KGAA Main Business Overview &nbsp;13.5.5 Merck KGAA Latest Developments &nbsp;13.6 Pfizer Inc. &nbsp;13.6.1 Pfizer Inc. Company Information &nbsp;13.6.2 Pfizer Inc. Antidepressant Medication Product Portfolios and Specifications &nbsp;13.6.3 Pfizer Inc. Antidepressant Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Pfizer Inc. Main Business Overview &nbsp;13.6.5 Pfizer Inc. Latest Developments &nbsp;13.7 Teva Pharmaceutical Industries Ltd. (Actavis Generics) &nbsp;13.7.1 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Company Information &nbsp;13.7.2 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Antidepressant Medication Product Portfolios and Specifications &nbsp;13.7.3 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Antidepressant Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Main Business Overview &nbsp;13.7.5 Teva Pharmaceutical Industries Ltd. (Actavis Generics) Latest Developments &nbsp;13.8 Takeda Pharmaceutical Limited Company. &nbsp;13.8.1 Takeda Pharmaceutical Limited Company. Company Information &nbsp;13.8.2 Takeda Pharmaceutical Limited Company. Antidepressant Medication Product Portfolios and Specifications &nbsp;13.8.3 Takeda Pharmaceutical Limited Company. Antidepressant Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Takeda Pharmaceutical Limited Company. Main Business Overview &nbsp;13.8.5 Takeda Pharmaceutical Limited Company. Latest Developments &nbsp;13.9 AstraZeneca &nbsp;13.9.1 AstraZeneca Company Information &nbsp;13.9.2 AstraZeneca Antidepressant Medication Product Portfolios and Specifications &nbsp;13.9.3 AstraZeneca Antidepressant Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 AstraZeneca Main Business Overview &nbsp;13.9.5 AstraZeneca Latest Developments 14 Research Findings and Conclusion

Report	Global Antidepressant Medication Market Growth 2025-2031
Selected License	Multi ID: LPI10767

Buyer Information

Order Summary